Aprea Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aprea Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2020 to Q3 2024.
  • Aprea Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -47.9 %, a 5.2% decline year-over-year.
  • Aprea Therapeutics, Inc. annual Return On Assets for 2023 was -52.4 %, a 82% increase from 2022.
  • Aprea Therapeutics, Inc. annual Return On Assets for 2022 was -291 %, a 432% decline from 2021.
  • Aprea Therapeutics, Inc. annual Return On Assets for 2021 was -54.8 %, a 11.5% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -47.9 -2.37 -5.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -46.3 -1.02 -2.25% Apr 1, 2024 Jun 30, 2024
Q1 2024 -46.1 +274 +85.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52.4 +239 +82% Oct 1, 2023 Dec 31, 2023
Q3 2023 -45.6 +214 +82.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -45.3 +189 +80.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -320 -261 -445% Jan 1, 2023 Mar 31, 2023
Q4 2022 -291 -236 -432% Oct 1, 2022 Dec 31, 2022
Q3 2022 -260 -202 -346% Jul 1, 2022 Sep 30, 2022
Q2 2022 -235 -180 -328% Apr 1, 2022 Jun 30, 2022
Q1 2022 -58.7 -3.69 -6.71% Jan 1, 2022 Mar 31, 2022
Q4 2021 -54.8 -5.64 -11.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -58.3 -15.3 -35.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -54.8 -13 -31% Apr 1, 2021 Jun 30, 2021
Q1 2021 -55 Jan 1, 2021 Mar 31, 2021
Q4 2020 -49.1 Oct 1, 2020 Dec 31, 2020
Q3 2020 -43 Jul 1, 2020 Sep 30, 2020
Q2 2020 -41.9 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.